Cargando…

New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease

Detalles Bibliográficos
Autor principal:	Ross, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611947/ https://www.ncbi.nlm.nih.gov/pubmed/31317110 http://dx.doi.org/10.1016/j.ekir.2019.04.015

Ejemplares similares

Searching for Second Hits for the Development of APOL1-Associated Kidney Disease
por: Husain, S. Ali, et al.
Publicado: (2019)

Launching APOLLO: The Role of APOL1 Genetic Variants in Live- and Deceased-Donor Kidney Transplantation
por: Fuentes, Federico, et al.
Publicado: (2019)

Focal segmental glomerulosclerosis and end-stage kidney disease in children
por: Gheissari, Alaleh
Publicado: (2015)

Association of APOL1 variants with mild kidney disease in first-degree relatives of African American patients with non-diabetic end stage renal disease
por: Freedman, Barry I., et al.
Publicado: (2012)

A Focus on APOL1 and Kidney Disease
por: Nestor, Jordan, et al.
Publicado: (2019)

APOL1-Associated Kidney Disease in Brazil
por: Riella, Cristian, et al.
Publicado: (2019)

4577 Resistant hypertension potentiates the risk of End-Stage Kidney Disease among African-Americans independent of APOL1 genotype in the Million Veteran Program
por: Akwo, Elvis, et al.
Publicado: (2020)

APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans
por: Matsha, Tandi E, et al.
Publicado: (2015)

SMOC2 gene interacts with APOL1 in the development of end-stage kidney disease: A genome-wide association study
por: Chaudhary, Ninad S., et al.
Publicado: (2022)

Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys
por: Blessing, Natalya A., et al.
Publicado: (2021)

APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene − Proceedings of the Henry Shavelle Professorship
por: Pollak, Martin R., et al.
Publicado: (2023)

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene
por: Tzur, Shay, et al.
Publicado: (2010)

APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin
por: Uzureau, Sophie, et al.
Publicado: (2020)

Transcription and translation of APOL1 variants
por: Ejaz, Samina
Publicado: (2017)

Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
por: McCarthy, Gizelle M., et al.
Publicado: (2021)

No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations
por: Kimuda, Magambo Phillip, et al.
Publicado: (2018)

Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV
por: Hung, Rachel K.Y., et al.
Publicado: (2022)

APOL1 Toxin, Innate Immunity and Kidney Injury
por: Limou, Sophie, et al.
Publicado: (2015)

APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans
por: Bentley, Amy R., et al.
Publicado: (2015)

Sequencing rare and common APOL1 coding variants to determine kidney disease risk
por: Limou, Sophie, et al.
Publicado: (2015)

APOL1 risk variants and kidney disease: what we know so far
por: Siemens, Tobias August, et al.
Publicado: (2018)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
por: Han, Jin, et al.
Publicado: (2021)

Insights into Living with Kidney Disease
por: Swallow, Veronica, et al.
Publicado: (2017)

Should kidney donors be genotyped for APOL1 risk alleles?
por: Freedman, Barry I., et al.
Publicado: (2015)

APOL1 Kidney-Risk Variants Induce Mitochondrial Fission
por: Ma, Lijun, et al.
Publicado: (2020)

Kidney Dysfunction After Acute Heart Failure: Is Acute Kidney Disease the New Acute Kidney Injury?
por: Kwong, Y. Diana, et al.
Publicado: (2021)

End of Life Care in End-Stage Kidney Disease
por: Prabhu, Ravindra Attur, et al.
Publicado: (2021)

The function of apolipoproteins L (APOLs): relevance for kidney disease, neurotransmission disorders, cancer and viral infection
por: Pays, Etienne
Publicado: (2020)

APOL1 genotyping via buccal mucosa cell samples to establish risk of kidney disease
por: Alladagbin, Dona Jeanne, et al.
Publicado: (2022)

Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations
por: Giudicelli, Giovanna Câmara, et al.
Publicado: (2022)

Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options
por: Vasquez-Rios, George, et al.
Publicado: (2023)

Machine learning to predict end stage kidney disease in chronic kidney disease
por: Bai, Qiong, et al.
Publicado: (2022)

Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?
por: Apetrii, Mugurel, et al.
Publicado: (2021)

Effect of APOL1 disease risk variants on APOL1 gene product
por: Haque, Shabirul, et al.
Publicado: (2017)

APOL1 Risk Genotypes Are Associated With Early Kidney Damage in Children in Sub-Saharan Africa
por: Ekulu, Pepe M., et al.
Publicado: (2019)

Brown tumor complicating end-stage kidney disease
por: Wiederkehr, Michael
Publicado: (2020)

APOL1 Genotype, Proteinuria, and the Risk of Kidney Failure: A Secondary Analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) Studies
por: Nguyen, Anthony, et al.
Publicado: (2022)

Fabry Disease Presenting as End-Stage Kidney Disease
por: Pahl, Madeleine V., et al.
Publicado: (2023)

306 Risk of Acute Kidney Injury in COVID-19 is Increased in African Americans With APOL1 High-Risk Genotype
Publicado: (2021)

The Risk of Stroke in Kidney Transplant Recipients with End-Stage Kidney Disease
por: Huang, Shih-Ting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lke3lgaiv02fkt0v45f1sv1ip0